FDA warns Amazon over nine unapproved drugs sold on its website for genital herpes and STI symptoms.
What happened
FDA reviewed labeling of products purchased on www.amazon.com in July 2026 and found nine products marketed for genital herpes or STI symptoms. FDA says Amazon introduced or delivered the products into interstate commerce through Fulfillment by Amazon. FDA says the products are unapproved new drugs because they are intended to treat disease and have no approved applications.
What FDA found
The products are drugs because their labeling says they relieve or treat genital herpes or STI symptoms.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128The products are new drugs not generally recognized as safe and effective, and FDA has not approved applications for them.
FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)Introducing or delivering these unapproved drugs into interstate commerce violates the law.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)Herstat GST claims relief from genital sores, which goes beyond the allowed uses in OTC Monograph M017.
FD&C Act section 505G; OTC Monograph M017Some products labeled homeopathic do not qualify for FDA's homeopathic guidance because they contain lemongrass, which is not listed in the Homeopathic Pharmacopeia of the United States.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); Homeopathic Pharmacopeia of the United States
What FDA wants
Send a written response within 15 business days to FDAAdvisory@fda.hhs.gov with specific corrective steps, preventive measures, root-cause explanation, and supporting documents, referencing 736006.
Who should pay attention
- online marketplaces and fulfillment providers
- sellers of OTC or homeopathic STI products
- brands relying on Amazon Fulfillment by Amazon
This is a summary. Read the original letter on fda.gov.